JPM26: Opus Genetics builds momentum in rare retinal gene therapy
Inherited retinal diseases encompass more than 350 genetic mutations and represent a significant unmet clinical need. Opus Genetics’ portfolio approach…
Analyst Comment
JPM26: Butterfly Network aims to close the global medical imaging gap
JPM26: Rakuten Medical unveils transformative photoimmunotherapy platform
JPM26: ICU Medical hopeful to ‘get out of the woods’ soon
JPM26: Integra resets by fixing supply and riding reimbursement tailwinds
JPM26: Ambu strengthens growth outlook as single-use endoscopy adoption grows
Intuitive Surgical expands platforms despite market headwind
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US
